PRASAD SUYASH (CMO and Head of R&D) received a stock award from TAYSHA GENE THERAPIES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/25/2020ACC: 0001209191-20-052116
Officer· CMO and Head of R&D
Since Sep 2020
+668.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
668.75K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+668.75K
Price / share
—
Trade value
—
% of position
New position
9/23/2020
0.00→668.75K
Total
Net shares
+668.75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/23/2020 | A · Award | +668.75K | — | — | New position | 0.00 | 668.75K |
| Total | +668.75K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported